IGF-1 and bone growth claims: what the science actually says

What did @tiwali actually say?

The transcript here is nearly unintelligible. The only recoverable line is something like "they have a soul of 30 of one single," which appears to be a garbled or auto-captioned fragment. The hashtags tell a clearer story: #bp (likely BPC-157), #nocturnalkent, #cope, #lookism, and #bones. The caption reads "just igf1 signal," suggesting the video's core argument is that IGF-1 signaling explains some physical trait, probably bone structure or facial development, a common theme in lookism-adjacent communities online.

Because the spoken transcript is effectively unusable, this fact-check treats the caption claim, that bone development or physical appearance is reducible to "just igf1 signal," as the primary assertion under review.

Does the science back this up?

No, not in the way the caption implies. IGF-1 (insulin-like growth factor 1) does play a real role in skeletal growth, but calling it the single driver of bone structure is a significant oversimplification. The science is more complicated than one signal doing all the work.

IGF-1 is produced primarily in the liver in response to growth hormone and acts on bone through both endocrine and local paracrine pathways. Studies confirm it stimulates osteoblast proliferation and longitudinal bone growth (Giustina et al., 2008, Endocrine Reviews). However, bone development is also regulated by Wnt signaling, BMP pathways, sex steroids, mechanical loading, and nutrition. A 2019 review in Bone by Mohan and Kesavan documented how IGF-1 knockout models still develop relatively normal skeletal architecture due to compensatory mechanisms, which alone undermines the "just IGF-1" framing.

What did they get wrong (or right)?

They got the existence of IGF-1's role right. It is genuinely important for bone growth, and the peptide community's interest in growth hormone secretagogues like ipamorelin or CJC-1295, which raise IGF-1, is not entirely without biological basis. Credit for pointing at a real pathway.

What they got wrong is the reductionism. "Just igf1 signal" implies a clean, singular mechanism. That is not what the literature shows. Facial bone development specifically, which lookism communities obsess over, involves neural crest cell migration, Hedgehog signaling, and in-utero hormonal environments that IGF-1 alone does not govern (Bhatt et al., 2013, Journal of Dental Research). Framing one peptide signal as the master switch for appearance is the kind of oversimplification that sends people toward unregulated peptide use chasing outcomes the biology does not support.

What should you actually know?

If you are looking at this video through the lens of peptide therapy, here is what matters. IGF-1 levels can be influenced by lifestyle factors including sleep, resistance training, and protein intake, all with stronger safety profiles than exogenous peptides. Compounded peptides that claim to raise IGF-1, such as CJC-1295 or ipamorelin, are not FDA-approved drugs, and their long-term safety data in healthy adults is limited to small or short-duration trials.

• The FDA has flagged several peptides previously available through compounding pharmacies, and regulatory status changes frequently.
• Elevated IGF-1 is not uniformly beneficial. High IGF-1 levels are associated with increased risk of certain cancers in epidemiological studies (Renehan et al., 2004, Lancet).
• No peptide currently available through telehealth has been shown in randomized controlled trials to alter adult craniofacial bone structure.

The "lookism" framing here is worth naming directly. It connects to online subcultures that promote unproven and sometimes dangerous interventions for appearance modification. That context matters when evaluating what this content is actually encouraging.